CLINICAL TRIAL
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
Add like
Add dislike
Add to saved papers

Local anaesthesia for awake fibreoptic nasotracheal intubation.

BACKGROUND: Awake fibreoptic nasotracheal intubation (FNI) is performed in potentially difficult airways under local anaesthesia. This observer-blinded study was designed to evaluate the efficacy of upper airway anaesthesia produced by nebulized lignocaine against combined regional block (CRB) for awake FNI.

METHODS: Forty-eight ASA 1 adults were randomly allocated to receive 4 ml of 4%-nebulized lignocaine (nebulization group) or translaryngeal block, bilateral superior laryngeal nerve block and three 4% lignocaine-soaked cotton swabs in the nose (CRB group). Facial grimace and patient comfort were assessed by grimace and airway reactivity scores. Patients reported their discomfort on a 4-point score.

RESULTS: All patients underwent successful FNI without significant discomfort; 79% in the nebulization group and 83% of the patients in the CRB group reported the procedure to be comfortable. A higher grimace score was recorded on insertion of the endotracheal tube (ETT) through the nostril in the nebulization group when compared to the CRB group, P<0.005. Similarly, patients in the CRB group were more comfortable during passage of the ETT into the glottis, as compared to the nebulization group. A progressive increase in heart rate was observed in all patients from the beginning of the procedure, but the rise in the nebulization group was greater, (P<0.05) and also lasted longer than in the CRB group (P<0.05). Mean arterial pressure was higher in the nebulization group when compared to the CRB group (P<0.05), with patients belonging to the CRB group demonstrating considerable haemodynamic stability.

CONCLUSIONS: Both nebulization and CRB produced satisfactory anaesthesia of the upper airway, but CRB provided better patient comfort and haemodynamic stability.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app